Clinical Trials

A Study of Patients Receiving High-Dose Rate Brachytherapy

Number: NCT00924027
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s):
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer

Number: NCT01581749
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 4
Sponsor(s): Albert DeNittis|Main Line Health
Sponsor Trial Information
Trial Location(s) and Contact(s):
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Number: NCT02040610
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Not Applicable
Sponsor(s):
Sponsor Trial Information
Trial Location(s) and Contact(s):
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Number: NCT02266745
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Promontory Therapeutics Inc.
Sponsor Trial Information
Trial Location(s) and Contact(s):
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer

Number: NCT02334579
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Not Applicable
Sponsor(s):
Sponsor Trial Information
Trial Location(s) and Contact(s):
Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Number: NCT02600156
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Not Applicable
Sponsor(s):
Sponsor Trial Information
Trial Location(s) and Contact(s):
Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer

Number: NCT02643667
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Washington University School of Medicine|Pharmacyclics LLC.
Sponsor Trial Information
Trial Location(s) and Contact(s):
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Number: NCT03424850
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 1|Phase 2
Sponsor(s): Washington University School of Medicine
Sponsor Trial Information
Trial Location(s) and Contact(s):
Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy

Number: NCT03496805
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Wake Forest University Health Sciences
Sponsor Trial Information
Trial Location(s) and Contact(s):
Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

Number: NCT03525262
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Texas Southwestern Medical Center|Boston Scientific Corporation
Sponsor Trial Information
Trial Location(s) and Contact(s):
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer

Number: NCT03654638
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Ohio State University Comprehensive Cancer Center|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s):
Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

Number: NCT03679260
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Cedars-Sinai Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s):
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

Number: NCT03716739
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Dana-Farber Cancer Institute|National Institute on Aging (NIA)
Sponsor Trial Information
Trial Location(s) and Contact(s):
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Number: NCT03769766
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 3
Sponsor(s): University of Texas Southwestern Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s):
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

Number: NCT03821246
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Lawrence Fong|Genentech, Inc.|University of California, San Francisco
Sponsor Trial Information
Trial Location(s) and Contact(s):
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

Number: NCT03824652
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Stephen Freedland|California Walnut Commission|Cedars-Sinai Medical Center
Sponsor Trial Information
Trial Location(s) and Contact(s):
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Number: NCT03860987
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC)
Sponsor Trial Information
Trial Location(s) and Contact(s):
A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Number: NCT04147806
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Albert Einstein College of Medicine
Sponsor Trial Information
Trial Location(s) and Contact(s):
Clinical Trial of Green Tea Catechins in Men on Active Surveillance

Number: NCT04300855
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute|National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s):
Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI)

Number: NCT04349501
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of California, San Diego
Sponsor Trial Information
Trial Location(s) and Contact(s):
Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland

Number: NCT04530552
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): National Cancer Institute (NCI)
Sponsor Trial Information
Trial Location(s) and Contact(s):
Prostate Imaging Using MRI +/- Contrast Enhancement

Number: NCT04571840
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Not Applicable
Sponsor(s):
Sponsor Trial Information
Trial Location(s) and Contact(s):
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer

Number: NCT04743934
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): Andrew McDonald|University of Alabama at Birmingham
Sponsor Trial Information
Trial Location(s) and Contact(s):
An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer

Number: NCT04777071
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): University of Washington
Sponsor Trial Information
Trial Location(s) and Contact(s):
Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer

Number: NCT04842890
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): The New York Proton Center
Sponsor Trial Information
Trial Location(s) and Contact(s):
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Number: NCT04879940
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Phase 2
Sponsor(s): H. Lee Moffitt Cancer Center and Research Institute
Sponsor Trial Information
Trial Location(s) and Contact(s):
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)

Number: NCT05424783
PHEN Patient Summary
ClinicalTrials.gov Information
Trial Phase: Not Applicable
Sponsor(s):
Sponsor Trial Information
Trial Location(s) and Contact(s):

Total: 27 Clinical Trials

PHEN,Inc. © 2025 All rights reserved